Skip to main content
Back
Watch Compare

BioAtla, Inc.

Data quality: 83%
BCAB
NASDAQ Manufacturing Chemicals
$4.46
▼ $0.06 (-1.33%)
Mkt Cap: 7.46 M
Price
$4.50
Mkt Cap
7.46 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -48.20 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC-1108.50%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio0.54
Interest CoverageN/A

Valuation

PE (TTM)
-0.13
Above sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1366 peers)
Metric Stock Sector Median
P/E -0.1 -1.5
P/B — 1.6
ROE % — -53.6
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

No analyst coverage available

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2026 — 0.0 —

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q32025 -$14.83 -$13.50 +9.0%
Q22025 -$14.67 -$16.00 -9.1%
Q12025 -$14.67 -$13.00 +11.4%
Q42024 -$19.00 -$15.00 +21.1%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -59.61 M
ROE N/A ROA -277.00%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -48.20 M
ROIC -1108.50% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.54
Interest Coverage N/A Asset Turnover N/A
Working Capital -8.31 M Tangible Book Value -31.24 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.13 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -646.50%
Market Cap 7.46 M Enterprise Value -863,829.0
Per Share
EPS (Diluted TTM) -1.01 Revenue / Share N/A
FCF / Share -29.09 OCF / Share -29.09
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 80.87%
SBC-Adj. FCF -54.71 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — 300,000.0 300,000.0
Net Income -59.61 M -69.78 M -123.46 M -106.48 M -95.40 M
EPS (Diluted) -1.01 -1.44 -2.58 -2.74 —
Gross Profit — — — — —
Operating Income -59.31 M -73.94 M -129.69 M -108.14 M -96.44 M
EBITDA — — — — —
R&D Expenses 43.57 M 63.10 M 103.73 M 79.35 M 58.27 M
SG&A Expenses — — — — —
D&A 373,000.0 925,000.0 1.22 M 1.20 M 1.33 M
Interest Expense — — — 0.0 3,000.0
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 13.83 M 52.42 M 119.66 M 225.74 M 254.42 M
Total Liabilities 50.02 M 38.16 M 48.99 M 45.40 M 43.60 M
Shareholders' Equity -36.19 M 14.27 M 70.67 M 180.34 M 210.82 M
Total Debt — — — — —
Cash & Equivalents 7.12 M 49.05 M 111.47 M 215.51 M 244.98 M
Current Assets 8.01 M 51.23 M 116.41 M 220.43 M 247.29 M
Current Liabilities 21.92 M 14.54 M 28.34 M 23.13 M 19.81 M